Melanie Leveridge, B.Sc.
GlaxoSmithKline, UK
Andrew Napper, Ph.D.
Evotec, USA
Track Chair:
Andreas Luippold, Ph.D.
Boehringer Ingelheim, Germany
Associate Track Chair:
Martin Giera, Ph.D.
Leiden University Medical Center, Netherlands
Track Chair:
Joe McGivern, Ph.D.
Amgen, USA
Associate Track Chair:
Melissa Crisp, Ph.D.
Eli Lilly, USA
Track Chair:
Sam Michael, Ph.D.
NIH, USA
Associate Track Chair:
Helen Plant, B.Sc.
AstraZeneca, UK
Track Chair:
Rob Howes, Ph.D.
AstraZeneca
Associate Track Chair:
Jan Reichert, Ph.D.
The Antibody Society, USA
Track Chair:
Jason Ekert, Ph.D
GlaxoSmithKline, USA
Associate Track Chair:
Nancy Allbritton, Ph.D.
University of North Carolina, USA
Track Chair:
Margaret Scott, Ph.D.
Genentech, USA
Associate Track Chair:
Tim Wigle, Ph.D.
Ribon Therapeutics, USA
Track Chair:
Yohann Potier, Ph.D.
Voyager Therapeutics
Associate Track Chair:
Nicola Richmond, Ph.D.
GlaxoSmithKline, UK
Track Chair:
Amar Basu, Ph.D.
Wayne State University, USA
Associate Track Chair:
Elodie Sollier, Ph.D.
Benkei, France
Track Chair:
Andrew Alt, Ph.D.
University of Michigan, USA
Associate Track Chair:
Guy Breitenbucher, Ph.D.
University of California San Francisco, USA
Track Chair:
Kristen Brennand, Ph.D.
Mount Sinai School of Medicine, USA
Associate Track Chair:
John Joslin, Ph.D.
Genomics Institute of the Novartis Research Foundation, USA
Diamond Sponsor
Diamond Sponsor
Diamond Sponsor
Diamond Sponsor
Diamond Sponsor
Diamond Sponsor
Platinum Sponsor
Platinum Sponsor
Platinum Sponsors
Platinum Sponsor
Platinum Sponsor
Platinum Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner
Media Partner